Novel therapies for sarcoidosis
- PMID: 17330197
- DOI: 10.1055/s-2007-970338
Novel therapies for sarcoidosis
Abstract
The treatment of sarcoidosis remains controversial. Corticosteroids remain the cornerstone of therapy, but immunosuppressive, cytotoxic, and immunomodulatory agents have emerged as viable therapeutic options for patients failing or experiencing adverse effects from corticosteroids. Published data are most extensive with methotrexate, but favorable responses have been noted with leflunomide, azathioprine, antimalarial and antimicrobial agents, and tumor necrosis factor-alpha inhibitors. This review focuses on these novel therapies for sarcoidosis, including indications for use, efficacy, toxicity, and monitoring.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources